Page 2 - Alvin Shih News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alvin shih. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alvin Shih Today - Breaking & Trending Today

RARE-X Announces the Expansion of its Board of Directors to Support the Organization's Growth and Launch Efforts


RARE-X Announces the Expansion of its Board of Directors to Support the Organization’s Growth and Launch Efforts
Share Article
New members will enhance RARE-X’s programs, pilots, and operational expansion with strategic expertise and leadership
“The additions of Cynthia Grossman, PhD, Jason Colquitt, and Simon Frost to the board are very strategic. All bring a depth of knowledge in patient advocacy, health tech, scaling-up organizations, and operational excellence,” said Nicole Boice, RARE-X Co-Founder/Executive Director.
ALISO VIEJO, Calif. (PRWEB)
February 10, 2021
RARE-X today announced three new board members who will help support the nonprofit’s work in structured patient data collection, responsible data sharing, and the promise of its Federated Data Sharing Platform for data sharing and analysis. The new board members are Cynthia Grossman, PhD, director at Biogen; Jason Col ....

South Africa , United States , United Kingdom , Cynthia Grossman , Wendy Erler , Phi Beta Kappa , Walt Kowtoniuk , Jason Colquitt , Angeli Moeller , Tom Hume , John Reynders , Betsy Bogard , Nicole Boice , Alvin Shih , Anthony Philippakis , Katherine Maynard , Craig Martin , Peter Goodhand , David Pearce , Broad Institute , National Science Foundation Incentives For Excellence Scholarship , American Heart Association , Milken Institute , Warren Alpert Medical School Of Brown University , Key Properties , Cystic Fibrosis Foundation ,

Catamaran Bio Announces Appointment of Dr. Alvin Shih as President and Chief Executive Officer


Press release content from Business Wire. The AP news staff was not involved in its creation.
Catamaran Bio Announces Appointment of Dr. Alvin Shih as President and Chief Executive Officer
February 4, 2021 GMT
Catamaran CEO Alvin Shih (Photo: Business Wire)
CAMBRIDGE, Mass. (BUSINESS WIRE) Feb 4, 2021
Catamaran Bio, Inc., a biotechnology company developing allogeneic CAR-NK cell therapies to treat diseases with significant unmet medical need, today announced the appointment of Alvin Shih, MD, MBA, as President and Chief Executive Officer. He has concurrently been appointed to the Board of Directors for Catamaran. Dr. Shih is an experienced biopharma executive with a track record of success in building companies across a broad spectrum of disease areas and therapeutic modalities, including cell and tissue therapies. ....

United Kingdom , United States , Kathryn Morris , Alvin Shih , Kevin Pojasek , Eli Lilly , Retrophin Inc , University Of Alabama , Sv Health Investors , Yates Network , Kellogg School Of Management At Northwestern University , Catamaran Bio Inc , Mckinsey Company , Chief Executive , Business Wire , Executive Chairman , Disarm Therapeutics , Enzyvant Therapeutics , Executive Vice President , Travere Therapeutics , Chief Operating Officer , Kellogg School , Massachusetts General , Sofinnova Partners , Lightstone Ventures , Takeda Ventures ,

Shih, fresh from selling Disarm to Lilly, takes up CEO post at CAR-NK specialist Catamaran


Catamaran Bio CEO Alvin Shih, M.D. (Catamaran Bio)
Catamaran Bio has named Alvin Shih, M.D., as CEO. Shih arrives at the allogeneic CAR-NK cell specialist fresh from leading Disarm Therapeutics to a takeover by Eli Lilly.
Massachusetts-based Catamaran is one of a clutch of companies trying to harness the attractive elements of natural killer (NK) cells, such as their off-the-shelf potential and ability to penetrate solid tumors, to create engineered cell therapies that improve on existing CAR-Ts. Catamaran broke cover with a $42 million series A last year and has now hired a CEO to oversee the use of the money. ....

Martin Shkreli , Alvin Shih , Kevin Pojasek , Eli Lilly , Syneos Health , Community Health Leaders , Clinical Research , Catamaran Bio , Disarm Therapeutics , Clinical Trial Diversity , Four Part Webinar Series , Featuring Pharma , Enzyvant Therapeutics , ஆல்வின் ஷிஹ் , எலி லில்லி , சமூக ஆரோக்கியம் தலைவர்கள் , மருத்துவ ஆராய்ச்சி , சட்டமரன் உயிர் , மருத்துவ சோதனை பன்முகத்தன்மை , நான்கு பகுதி வெபினார் தொடர் , இடம்பெறும் பார்மா ,